HomeCompareTLLEQ vs MRK

TLLEQ vs MRK: Dividend Comparison 2026

TLLEQ yields 43478.26% · MRK yields 2.76%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 TLLEQ wins by $247040391.60M in total portfolio value
10 years
TLLEQ
TLLEQ
● Live price
43478.26%
Share price
$0.00
Annual div
$2.00
5Y div CAGR
-50%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$247040391.66M
Annual income
$43,855,647,456,379.03
Full TLLEQ calculator →
MRK
Merck & Co. Inc.
● Live price
2.76%
Share price
$120.31
Annual div
$3.32
5Y div CAGR
32.7%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$56.8K
Annual income
$9,798.13
Full MRK calculator →

Portfolio growth — TLLEQ vs MRK

📍 TLLEQ pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodTLLEQMRK
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, TLLEQ + MRK cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
TLLEQ pays
MRK pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

TLLEQ
Annual income on $10K today (after 15% tax)
$3,695,652.17/yr
After 10yr DRIP, annual income (after tax)
$37,277,300,337,922.17/yr
MRK
Annual income on $10K today (after 15% tax)
$234.56/yr
After 10yr DRIP, annual income (after tax)
$8,328.41/yr
At 15% tax rate, TLLEQ beats the other by $37,277,300,329,593.76/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of TLLEQ + MRK for your $10,000?

TLLEQ: 50%MRK: 50%
100% MRK50/50100% TLLEQ
Portfolio after 10yr
$123520195.86M
Annual income
$21,927,823,733,088.59/yr
Blended yield
17.75%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

TLLEQ
No analyst data
Altman Z
-5.1
Piotroski
3/9
MRK
Analyst Ratings
25
Buy
11
Hold
1
Sell
Consensus: Buy
Price Target
$128.54
+6.8% upside vs current
Range: $100.00 — $150.00
Altman Z
4.0
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

TLLEQ buys
0
MRK buys
0
No recent congressional trades found for TLLEQ or MRK in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricTLLEQMRK
Forward yield43478.26%2.76%
Annual dividend / share$2.00$3.32
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR-50%32.7%
Portfolio after 10y$247040391.66M$56.8K
Annual income after 10y$43,855,647,456,379.03$9,798.13
Total dividends collected$219836974.86M$28.9K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: TLLEQ vs MRK ($10,000, DRIP)

YearTLLEQ PortfolioTLLEQ Income/yrMRK PortfolioMRK Income/yrGap
1← crossover$2,184,613$2,173,913.04$11,206$366.19+$2.17MTLLEQ
2$224,260,844$221,923,307.95$12,650$502.35+$224.25MTLLEQ
3$10,885,508,359$10,645,549,255.70$14,407$694.19+$10885.49MTLLEQ
4$253,109,922,261$241,462,428,317.05$16,585$967.82+$253109.91MTLLEQ
5$2,894,419,299,081$2,623,591,682,262.40$19,342$1,363.89+$2894419.28MTLLEQ
6$17,116,600,374,718$14,019,571,724,700.50$22,913$1,947.19+$17116600.35MTLLEQ
7$57,056,316,605,662$38,741,554,204,714.47$27,662$2,823.89+$57056316.58MTLLEQ
8$121,396,397,421,357$60,346,138,653,297.84$34,159$4,173.35+$121396397.39MTLLEQ
9$189,892,284,303,883$59,998,139,063,030.98$43,337$6,308.80+$189892284.26MTLLEQ
10$247,040,391,661,533$43,855,647,456,379.03$56,776$9,798.13+$247040391.60MTLLEQ

TLLEQ vs MRK: Complete Analysis 2026

TLLEQStock

Teletouch Communications, Inc. provides wireless services and consumer electronics to individual consumers, businesses, and government agencies in the United States and internationally. It offers wireless telecommunications solutions, including cellular, GPS-telemetry, and wireless messaging. Teletouch Communications serves approximately 38,000 cellular customers. The company also provides its products and services through a chain of 19 retail and agent stores under the Teletouch and Hawk Electronics brand names; direct sales force; and through various retail e-commerce Websites. In addition, it operates a consumer electronics and cellular equipment wholesale distribution business, primarily serving carrier agents, rural cellular carriers, smaller consumer electronics, and automotive retailers and auto dealers. The company acquires, sells, and supports various types of cellular telephones, related accessories, telemetry, car audio, and car security products under various direct distribution agreements with manufacturers. Teletouch Communications, Inc. was founded in 1964 and is headquartered in Fort Worth, Texas. On October 3, 2013, Teletouch Communications Inc., along with its affiliate, filed a voluntary petition for liquidation under Chapter 7 in the US Bankruptcy Court for the District of Delaware.

Full TLLEQ Calculator →

MRKHealthcare

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.

Full MRK Calculator →
📬

Get this TLLEQ vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

TLLEQ vs SCHDTLLEQ vs JEPITLLEQ vs OTLLEQ vs KOTLLEQ vs MAINTLLEQ vs JNJTLLEQ vs ABBVTLLEQ vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.